Cord Blood and Stem Cell News

Chrissy Teigen Stores Cord Blood & Tissue for her new baby

"As part of my pregnancy, I learned banking my baby's newborn stem cells gives us access to current treatments and future clinical therapies, if my child ever needs them. We knew this was something we wanted to do – as a mom, I want to make sure our children have every possible option available to them."

Cell Care Joins the Generate Life Sciences Family to Create a Global Platform

Cell Care, Australia’s leading cord blood bank, today announced it has been acquired by Generate Life Sciences (Generate). Generate operates Cord Blood Registry (CBR), North America’s largest cord blood bank and one of the world’s preeminent stem cell R&D organisations.

Generate joins CooperSurgical, advancing the health of women, babies and families

In November 2021 it was announced that CooperCompanies acquired Generate Life Sciences under its CooperSurgical banner. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics.

Umbilical cord mesenchymal stem cells used for COVID-19 trial

Doctors in Florida say a clinical trial using stem cells from cord tissue has been incredibly successful in treating patients with severe cases of COVID-19. Patients from Jackson Memorial Hospital and the University Miami Tower are involved, with many of them with acute respiratory distress syndrome (ARDS).

Ash Pollard chooses to store her baby’s stem cells with Cell Care

Ash Pollard needs no introduction. After announcing her pregnancy earlier in the year, we are excited that Ash has decided to store her baby’s cord blood and tissue with Cell Care. Ash attended a Tummy Talks antenatal class and this is where she heard about cord blood banking. Listen to the discussion between Midwife Cath...

Covid-19 Cord Blood Trial

Channel 7 News have reported cord blood-derived cells are being used in a world first clinical trial to treat COVID-19. Monash University and Monash Health are undertaking the trial for severe COVID-19 patients who are anticipated to improve within 24 hours of cord blood treatment.

COVID-19 and Umbilical Cord Tissue

The impact of COVID-19 is being felt worldwide and there is a tremendous amount of research being undertaken to understand this disease, prevent its transmission, and treat those infected. Patients with COVID-19 can present with little to no symptoms, cold or flu like symptoms, or in severe cases, can progress to pneumonia, sometimes leading to death.

COVID-19 Update

As the potential consequences of the coronavirus (COVID-19) are felt across many aspects of our lives, we’re reaching out to update our client families. We want to anticipate potential questions regarding the impact of the virus on cord blood collection, storage and therapeutic use.